Cisatracurium Besylate Injection, Solution
Product Images NDC 0409-1208

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 0409-1208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cisatracurium 01)

Chemical structure of Cisatracurium Besylate, a bis-quaternary ammonium compound with methoxy-substituted aromatic rings and an associated besylate counterion.*

FDA Label Image

Figure 1 (Cisatracurium 02)

A scatter plot graph showing data points clustered near the center, with horizontal and vertical axes representing percentage changes from -60% to +60%. The horizontal axis is labeled MAP, and the vertical axis is labeled HR, suggesting a comparison of mean arterial pressure and heart rate changes.*

FDA Label Image

Figure 2 (Cisatracurium 03)

A scatter plot chart showing data points centered around intersecting axes labeled with percentage changes. The vertical axis is labeled HR with values from -60% to +60%, and the horizontal axis is labeled MAP with the same percentage range. Data points are clustered near the center intersection of the axes.*

FDA Label Image

Logo (Cisatracurium 04)

FDA Label Image

Principal Display Panel (5 mL Vial Label)

Label for Cisatracurium Besylate Injection, USP, 10 mg per 5 mL (2 mg/mL) single-dose vial. The label includes warnings about its paralytic effects and respiratory arrest risk. Instructions specify refrigeration storage at 2 to 8°C, protection from light, and no freezing. Distributed by Hospira, Inc., with space for lot number, expiration date, and discard date.*

FDA Label Image

Principal Display Panel (5 mL Vial Carton)

Packaging label for Cisatracurium Besylate Injection, USP 10 mg/5 mL (2 mg/mL) solution for intravenous use. The label indicates the product comes in 10 x 5 mL single-dose vials, labeled as a paralyzing agent. The manufacturer is Hospira, Inc., and the label includes warnings about respiratory arrest and instructions for storage and handling. The NDC is 0409-1098-02.*

FDA Label Image

Principal Display Panel (20 mL Vial Label)

Label for Cisatracurium Besylate Injection, USP 200 mg/20 mL (10 mg/mL) single-dose vial by Hospira, Inc. The label includes warnings about it being a paralyzing agent for ICU use only, requiring facilities to have artificial respiration available. Storage instructions specify refrigeration at 2 to 8°C, protection from light, and no freezing.*

FDA Label Image

Principal Display Panel (20 mL Vial Carton)

Carton label for Cisatracurium Besylate Injection, USP, 200 mg/20 mL (10 mg/mL) intravenous injection by Hospira, Inc. The label indicates 10 single-dose 20 mL vials and includes warnings that it is a paralyzing agent for ICU use only. The label also provides storage instructions, manufacturer details, and a barcode.*

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Cisatracurium Besylate Injection, USP 20 mg/10 mL (2 mg/mL) in a 10 mL multiple-dose vial label. The label shows it contains 0.9% benzyl alcohol as a preservative and includes warnings about its use as a paralyzing agent requiring artificial respiration facilities. Storage instructions and distributor information for Hospira, Inc. are also present.*

FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Packaging label for Cisatracurium Besylate Injection, USP, 20 mg/10 mL (2 mg/mL) multiple-dose vials by Hospira, Inc. The label highlights the product's concentration, preserving agent 0.9% benzyl alcohol, and administration route as intravenous injection. It includes warnings about the drug's paralytic effect and the necessity of facilities for artificial respiration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.